Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma Research Letter
| Authors: | Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; Landau, H. J.; Scordo, M.; Shah, G. L.; Giralt, S. A.; Pianko, M. J.; Burge, M.; Barnett, K.; Salcedo, M.; Caple, J.; Tran, L.; Blaslov, J.; Shekarkhand, T.; Hamid, S.; Nemirovsky, D.; Derkach, A.; Arisa, O.; Peer, C. J.; Figg, W. D.; Usmani, S. Z.; Landgren, O.; Lesokhin, A. M. |
| Title: | Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma |
| Keywords: | adult; clinical article; controlled study; aged; middle aged; lenalidomide; fatigue; diarrhea; drug dose reduction; drug efficacy; drug safety; cancer patient; drug megadose; letter; quality of life; bortezomib; multiple myeloma; phase 2 clinical trial; maintenance therapy; dexamethasone; melphalan; autologous stem cell transplantation; cancer regression; blood sampling; evening dosage; morning dosage; open study; drug blood level; drug therapy; carfilzomib; complication; patient-reported outcome; liquid chromatography-mass spectrometry; colesevelam; Common Terminology Criteria for Adverse Events; humans; human; male; female; daratumumab |
| Journal Title: | Blood Cancer Journal |
| Volume: | 14 |
| ISSN: | 2044-5385 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2024-09-19 |
| Start Page: | 164 |
| Language: | English |
| DOI: | 10.1038/s41408-024-01136-1 |
| PUBMED: | 39300066 |
| PROVIDER: | scopus |
| PMCID: | PMC11412964 |
| DOI/URL: | |
| Notes: | Letter -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- MSK corresponding author is Malin Hultcrantz -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
